Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Experimental Oncology|May 13, 2022
EXPRESSION OF MARKERS OF BONE TISSUE REMODELING IN BREAST CANCER AND PROSTATE CANCER CELLS IN VITRON Lukianova, T Zadvornyi, E Kashuba, et al.Experimental Oncology|March 6, 2026
ASSOCIATIONS OF TUMOR-ASSOCIATED MACROPHAGE INFILTRATION WITH CYTOKINE EXTRACELLULAR MATRIX SIGNATURES IN BREAST CANCER MICROENVIRONMENTA Pavlova, O Mushii, T Zadvornyi, et al.Experimental Oncology|July 17, 2025
СIRCULATING MIRNAS AS PREDICTIVE MARKERS FOR LINE I AND II NEOADJUVANT CHEMOTHERAPY IN TRIPLE-NEGATIVE BREAST CANCERT V Borikun, V Bazas, T Zadvornyi, et al.BMC Pharmacology & Toxicology|June 8, 2022
Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo modelsN Bezdieniezhnykh, A Lykhova, T Kozak, et al.Experimental Oncology|October 8, 2025
STRESS-INDUCED MODULATION OF THE TUMOR MICROENVIRONMENT: MECHANISMS AND IMPLICATIONS FOR CANCER PROGRESSIONV Chekhun, T Burda, O Mushii, et al.Experimental Oncology|August 14, 2022
EXPRESSION OF OSTEOPONTIN AND OSTEONECTIN IN BREAST AND PROSTATE CANCER CELLS WITH DIFFERENT SENSITIVITY TO DOXORUBICINT Zadvornyi, N Lukianova, T Borikun, et al.Experimental Oncology|June 9, 2024
EXPRESSION OF SPP1 AND SPARC GENES IN TUMOR TISSUE OF PATIENTS WITH BREAST CANCERV Chekhun, A Pavlova, T Zadvornyi, et al.Experimental Oncology|January 8, 2024
SIGNIFICANCE OF OSTEOPONTIN FOR PREDICTING AGGRESSIVENESS OF PROSTATE CANCERN Lukianova, Т Zadvornyi, Т Borikun, et al.BMC Genomics|July 1, 2016
Negative selection maintains transcription factor binding motifs in human cancerIlya E Vorontsov, Grigory Khimulya, Elena N Lukianova, et al.Experimental Oncology|January 8, 2024
FEATURES OF COL1A1 EXPRESSION IN BREAST CANCER TISSUE OF YOUNG PATIENTSV Chekhun, O Mushii, T Zadvornyi, et al.Pageof 3